Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittlin

Showing results (251-260 of 318) with videos related to

Pageof 32
Sort By:
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
Journal of Medicinal Chemistry|October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial ImidazopyridazinesClaire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse ModelAndré Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo EfficacyBeatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
Chemmedchem|July 30, 2016
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of ActionChristoph Boss, Hamed Aissaoui, Nathalie Amaral, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life CycleClaire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
Pageof 32

Showing results (251-260 of 318) with videos related to

Sort By:
Pageof 32
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
Journal of Medicinal Chemistry|October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial ImidazopyridazinesClaire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
ACS Infectious Diseases|February 28, 2023
7-<i>N</i>-Substituted-3-oxadiazole Quinolones with Potent Antimalarial Activity Target the Cytochrome <i>bc</i><sub>1</sub> ComplexWilliam Nguyen, Madeline G Dans, Iain Currie, et al.
Journal of Medicinal Chemistry|October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse ModelAndré Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 9, 2011
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaSusan A Charman, Sarah Arbe-Barnes, Ian C Bathurst, et al.
Journal of Medicinal Chemistry|January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry|September 16, 2016
Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo EfficacyBeatriz Baragaña, Neil R Norcross, Caroline Wilson, et al.
Chemmedchem|July 30, 2016
Discovery and Characterization of ACT-451840: an Antimalarial Drug with a Novel Mechanism of ActionChristoph Boss, Hamed Aissaoui, Nathalie Amaral, et al.
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life CycleClaire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
Pageof 32